CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7 enrolled
Drug / intervention
BrainPortdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02643238
NCT02643238N/ACompleted
CompareCT.gov

Continued Study of Artificial Vision: Evaluation of the BrainPort® System and Investigation of Visual Ambulation

Akron Children's Hospital·interventional·Posted Dec 31, 2015·Updated Nov 16, 2022

In Brief

A clinical study evaluating BrainPort for Blindness. Completed, enrolled 7 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the use of an artificial vision system called Brainport system in blind patients To investigate visual, and oculomotor (eye motion) mechanisms involved in the use of the Brainport system.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBlindness
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedDec 31, 2015
Enrollment StartOct 1, 2011
Primary CompletionDec 1, 2016
Study CompletionMay 1, 2022
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 10.5 years ago

Interventions

BrainPortdevice

This system is a novel, bionic, non-invasive, vision bypass system that conveys environment images from a spectacle-frame-mounted video-camera to the brain via an electro-tactile tongue array. The electro-tactile stimulation delivered by the tongue-array placed on the tongue allows users to interpret the images of objects in their camera's visual field